Friday, 18 September 2015

PAY IT FORWARD: Fundraiser for UShaka's Wayne Scott Chronic Myeloid Leukemia Treatment Costs

By the end of this post, you will have had 4 opportunities to assist this family. Even if it is a small amount, every single cent will help. I have hyperlinked any points of interest - take care my friends, and remember to message me if any of you have any similar needs (health related fundraising etc) 

Treatment of ChronicMyeloid Leukemia (CML) for Wayne Scott

"I trust this letter finds you well.
Wayne Scott has been suffering with Chronic Myeloid Leukemia (CML) since 2010.
Various forms of oral chemotherapy has been administered by the patient’s oncology doctors such as Gleevec, Tasignia, etc. and he also received intravenous chemotherapy treatment in November 2014 and February 2015. 
To date, none of these treatments seemed to be successful to cure the disease and the only positive prognosis will be a bone marrow stem cell transplant. The member has subsequently been granted temporary disability (1 July 2015) as he is not able to perform his daily duties as Entertainment and Events Manager of uShaka Marine World in Durban.
Dr. J.P. Singh (Practice number 0336254) has done intensive research and testing to find a positive stem-cell donor and we have received the news that a match has been found and identified as a 100% match whom resides in Germany."

To donate to this cause CLICK HERE

"Wayne’s CML is currently in Accelerated Phase and it will be life threatening to do the transplant while he is in this phase.
Dr. Singh’s research has resulted in finding an oral drug Ponatinib (trade name Iclusig, previously AP24534) which is an oral drug developed by ARIAD Pharmaceuticals for the treatment of Chronic Myeloid Leukemia (CML), which in his treatment plan would like the patient to use for 3 months before and 3 months after the bone marrowstem cell transplant.
Dr. Singh has submitted a treatment plan to Wayne’s Medical Aid, which includes Ponatinib and we have received an authorization for treatment from Wayne’s medical aid that they are willing to only pay 50% of the costs to obtain the drug Ponatinib. It is an extremely expensive medication, which Wayne will not be able to afford, although the use thereof will be beneficial to the patient and will improve his current condition to a level, which will allow Dr. Singh to execute the transplant successfully. The prognosis of the transplant promises to be positive."
To donate to this cause CLICK HERE

"We are pleading to you to assist us in any donation as the cost of this medication for the next three months amounts to R330,000 which the medical aid will contribute R165,000 of. That means, Wayne have to find R165,000 for the co-payment and the first R55,000 is due on Monday, 28 September."

Side note from Sandy: This is a LOT of money for the average South African. 

"We pray that you will find it in your heart to be of assistance for this last hurdle to cure the CML, which Wayne Scott suffers from.
There are TWO ways to assist, either donate to this cause CLICK HERE or, We have opened a separate bank account for the fundraising and the details are as follows:

Account holder: Andre B van Wyk
Bank: First National Bank
Branch: 255355
Account Number: 62555480377

Reference: Kindly use your name and surname or company name. Should you choose to remain anonymous, please use reference as “Wayne”

Should you require any additional information, please do not hesitate to contact us.
God bless."

1 comment:

  1. Dear Sandy.

    Words cannot describe our gratitude and we are humbled by your kindness and effort by publishing this. We appreciate your assistance and love you from the bottom of our hearts.

    Wayne & Andre-B


All comments are moderated by the blogger.
Only formative discussive comments will be allowed.
No insults, slurs or rude comments will be allowed.
ALL content is copyrighted and belongs to the Author, all images provided by outside sources are 'loaned' to this blog by consent.
NO COPYING of images for distribution in any form are allowed.
Email the author for permission.